Isodiol International (Isodiol International) Debt-to-Equity : -14.14 (As of Dec. 2019)

View and export this data going back to 2014. Start your Free Trial

What is Isodiol International Debt-to-Equity?

Isodiol International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $0.13 Mil. Isodiol International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $4.31 Mil. Isodiol International's Total Stockholders Equity for the quarter that ended in Dec. 2019 was $-0.31 Mil. Isodiol International's debt to equity for the quarter that ended in Dec. 2019 was -14.14.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Isodiol International's Debt-to-Equity or its related term are showing as below:

ISOLF's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Isodiol International Debt-to-Equity Historical Data

The historical data trend for Isodiol International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isodiol International Debt-to-Equity Chart

Isodiol International Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Debt-to-Equity

Get a 7-Day Free Trial

-0.95

-1.26

0.13

1.17

Isodiol International Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Debt-to-Equity	Get a 7-Day Free Trial															0.09	1.17	1.68	9.18	-14.14

Competitive Comparison of Isodiol International's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Isodiol International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Isodiol International's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Isodiol International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Isodiol International's Debt-to-Equity falls into.

Isodiol International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Isodiol International's Debt to Equity Ratio for the fiscal year that ended in Mar. 2019 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.173	+	3.882)	/	5.185
	=	1.17

Isodiol International's Debt to Equity Ratio for the quarter that ended in Dec. 2019 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.129	+	4.31)	/	-0.314
	=	-14.14

Isodiol International (OTCPK:ISOLF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Isodiol International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Isodiol International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Isodiol International (Isodiol International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Isodiol International Inc (OTCPK:ISOLF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Granville Street, Suite 2710, Vancouver, BC, CAN, V6C 1S4

Website

https://www.isodiol.com

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.